Filter
2038
Filtered Results: 2038
Text search:
hiv
drug
resistance
Featured
Recommendations
218
New Publications
581
Language
Document type
No document type
1331
Guidelines
258
Studies & Reports
245
Manuals
68
Strategic & Response Plan
52
Fact sheets
34
Training Material
30
Situation Updates
11
Infographics
7
Resource Platforms
1
Videos
1
Countries / Regions
India
98
South Africa
70
Kenya
59
Western and Central Europe
57
Tanzania
46
Global
45
Ethiopia
45
Eastern Europe
42
Uganda
41
Zambia
39
Nepal
34
Nigeria
33
Malawi
31
Namibia
31
Africa
29
Liberia
27
Ghana
26
Sierra Leone
26
Bangladesh
24
Asia
23
Lesotho
22
Rwanda
22
Philippines
20
Myanmar / Burma
20
Cambodia
19
Zimbabwe
18
Latin America and the Carribbean
18
Ukraine
17
Russia
14
Senegal
13
South–East Asia Region
13
Botswana
13
Indonesia
13
Mozambique
10
Cameroon
8
Albania
8
Eswatini/ Swaziland
8
Colombia
7
Burkina Faso
7
Thailand
6
Congo, Democratic Republic of
6
Argentina
6
Pakistan
6
Venezuela
5
Germany
5
Georgia
5
West and Central Africa
4
Middle East and North Africa
4
East and Southern Africa
4
Vietnam
4
North Macedonia
3
Tajikistan
3
Benin
3
Estonia
3
Guinea
3
Haiti
3
Jordan
3
Eastern Europe and Central Asia
3
El Salvador
2
China
2
Syria
2
Iran
2
Laos
2
Armenia
2
Western Pacific Region
2
Lebanon
2
Papua New Guinea
2
Moldova
2
Sudan
2
Central African Republic
2
Mali
2
Bhutan
2
Somalia
2
Switzerland
1
Timor Leste/ East Timor
1
Turkey
1
Gambia
1
Kazakhstan
1
Afghanistan
1
Peru
1
Morocco
1
Qatar
1
USA
1
Saudi Arabia
1
Paraguay
1
North America
1
Gabon
1
Uruguay
1
Turkmenistan
1
France
1
Tunisia
1
Côte d’Ivoire / Ivory Coast
1
Brazil
1
Sri Lanka
1
Romania
1
Greece
1
Chad
1
South Sudan
1
Iraq
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
786
Clinical Guidelines
221
Women & Child Health
65
Public Health
61
Key Resources
46
Capacity Building
23
Pharmacy & Technologies
22
Annual Report MEDBOX
1
Toolboxes
TB
459
HIV
353
AMR
146
Mental Health
47
Pharmacy
43
NTDs
43
COVID-19
36
Caregiver
34
Malaria
30
Rapid Response
28
Refugee
26
Ebola & Marburg
23
Global Health Education
19
Polio
16
Health Financing Toolbox
15
Planetary Health
12
NCDs
11
Conflict
9
Cholera
7
Disability
5
Natural Hazards
4
Zika
2
Specific Hazards
1
Social Ethics
1
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis treatment outcomes in Burkina Faso. The current study investigated the factors associated with tuberculosis treatment failure in the central east ...
May 2018
HIV i-Base
ISSN 1475-2077 www.i-Base.info
Watch for out-of-date information
First questions
You and your doctor Resistance and adherence Treatment choices
Antimicrobial Resistance Surveillance and Research Network | This manual describes well accepted methods to carry out drug susceptibility testing on important gram positive and gram negative clinically relevant bacteria. Methods of specimen collection, transport, culture, anti-microbial drug suscept...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective pack...
HIV infection, due to the immunosuppressant that leads, nowadays constitutes an aggravating factor of endemic tuberculosis. Tuberculosis remains a huge burden to human health, even in the early 21st century. The situation is deteriorating in many countries, particularly because of the synergy with t...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
Zambia has completed the implementation of the National TB Strategic Plan (2017-2021) that set in motion the TB elimination agenda in Zambia through coordinated and accelerated TB response. During this period, the National TB and Leprosy Programme (NTLP) registered tremendous success.
The NTLP is ...
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
This job aid provides information for laboratorians about how to receive, process, and store dried blood spot specimens collected for early infant diagnosis, viral load, or drug resistance testing.
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa...
